Philip Morris International Inc., a leading tobacco company, is committed to becoming a 100% smoke-free entity. By March 2025, 42% of revenue was from smoke-free products like IQOS and ZYN. The firm is advancing digital transformation and tech initiatives to enhance health-focused and prescription products. Philip Morris International Inc., a leading tobacco company, is committed to becoming a 100% smoke-free entity. By March 2025, 42% of revenue was from smoke-free products like IQOS and ZYN. The firm is advancing digital transformation and tech initiatives to enhance health-focused and prescription products.
Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.
PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.
Tobacco Industry | Consumer Defensive Sector | Mr. Jacek Olczak CEO | XMIL Exchange | US7181721090 ISIN |
US Country | 83,100 Employees | 20 Mar 2025 Last Dividend | - Last Split | 17 Mar 2008 IPO Date |